Showing 41 - 60 results of 355 for search '"pulmonary artery"', query time: 0.08s Refine Results
  1. 41

    Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis by E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk

    Published 2015-01-01
    “…A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a possible drug-induced cause of PAH in the most recent classification of pulmonary hypertension. …”
    Get full text
    Article
  2. 42
  3. 43
  4. 44

    Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis by Rui-Qi Wei, Wen-Mei Zhang, Zhe Liang, Chunmei Piao, Guangfa Zhu

    Published 2022-01-01
    “…Pulmonary arterial hypertension (PAH) is a progressive and complex pulmonary vascular disease with poor prognosis. …”
    Get full text
    Article
  5. 45
  6. 46
  7. 47
  8. 48

    Pulmonary Hypertension due to a Pulmonary Artery Leiomyosarcoma: A Case Report by Seyyed Hassan Adeli, Bardia Nemati, Mahboubeh Jandaghi, Mohammad Mahdi Riahi, Fatemeh Hosseinzadeh, Fatemeh Salarvand

    Published 2013-01-01
    “…Background. Primary pulmonary artery sarcomas are very rare and their histologic type, called leiomyosarcoma, is even rarer. …”
    Get full text
    Article
  9. 49
  10. 50

    Rare Case of a Calcified Catheter-Related Sheath Embolizing to the Right Pulmonary Artery by Lee K. Rousslang, Jonathan R. Wood

    Published 2020-01-01
    “…We report the case of catheter-related sheath embolization to the right pulmonary artery in a child, as confirmed on CT.…”
    Get full text
    Article
  11. 51

    Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension by Liu H, Liu S, Ma P, Ma L, Liu Y, Zhao F, Zhou R

    Published 2025-01-01
    “…Furthermore, the concentrations of aloperine in the lungs of the NLCs group were 1.79, 3.78, and 2.30 times higher than those in the solution group at three time points (0.25 h, 1.5 h, 4 h), suggesting that NLCs can increase the accumulation of aloperine in the lungs.Conclusion: Our findings suggest that NLCs loaded with aloperine could offer a promising strategy for the treatment of pulmonary arterial hypertension.Keywords: aloperine, nanostructured lipid carrier, aerosol inhalation, pharmacokinetics…”
    Get full text
    Article
  12. 52

    Extranodal Rosai–Dorfman Disease Presenting as a Mediastinal Mass with Pulmonary Artery Invasion by Andrew R. Orr, Daniel Lefler, C. Deshpande, Pallavi Kumar

    Published 2018-01-01
    “…While case reports of extranodal involvement in nearly every organ system exist, documented instances of mediastinal and pulmonary artery involvement are particularly rare. This study describes the case of a middle-aged woman presenting with new onset right heart failure who was found to have extranodal RDD in the form of a large mediastinal mass with invasion and occlusion of the main pulmonary arteries.…”
    Get full text
    Article
  13. 53
  14. 54

    Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension by David Langleben, Stephen Archer, John Granton, Andrew M Hirsch, Robert D Levy, Sanjay Mehta, Evangelos Michelakis, Duncan J Stewart

    Published 2005-01-01
    “…The Canadian Cardiovascular Society and the Canadian Thoracic Society requested a position statement on pulmonary arterial hypertension from leading Canadian experts. …”
    Get full text
    Article
  15. 55

    Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension by Bodil Ivarsson, Björn Ekmehag, Trygve Sjöberg

    Published 2014-01-01
    “…Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal, noncurable, but treatable diseases that strongly affect the patients. …”
    Get full text
    Article
  16. 56

    CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats by Hua Guan, Xiaofeng Yang, Tao Shi, Yongjian Zhang, Aoqi Xiang, Yongxin Li

    Published 2021-01-01
    “…The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. …”
    Get full text
    Article
  17. 57
  18. 58
  19. 59

    The Association of the Pulmonary Artery Pulsatility Index and Right Ventricular Function after Cardiac Surgery by Johnny Wei, Abigail Kee, Rachel Dukes, Jack Franke, Vincent Leonardo, Brigid C. Flynn

    Published 2024-01-01
    “…Background. The pulmonary artery pulsatility index (PAPi) has been shown to correlate with right ventricular (RV) failure in patients with cardiac disease. …”
    Get full text
    Article
  20. 60

    In Situ Thrombosis of Small Pulmonary Arteries in Pulmonary Hypertension Developing after Chemotherapy for Malignancy by Kay Maeda, Yoshikatsu Saiki, Shigeo Yamaki

    Published 2015-01-01
    “…Autopsy showed complete occlusion of the peripheral small pulmonary arteries and veins by thrombi. These results demonstrate that in situ thrombosis in the small pulmonary arteries could cause pulmonary hypertension after chemotherapy.…”
    Get full text
    Article